Melanoma News and Research

Latest Melanoma News and Research

Cancer therapy with common cold virus

Cancer therapy with common cold virus

Loyola dermatologists to offer free melanoma screenings in May

Loyola dermatologists to offer free melanoma screenings in May

Delcath closes $20M credit facility

Delcath closes $20M credit facility

Health Discovery launches MelApp for melanoma risk assessment

Health Discovery launches MelApp for melanoma risk assessment

Immunotherapy may also help elderly cancer patients

Immunotherapy may also help elderly cancer patients

RiboMed releases multi-marker methylation prognostic test for glioma

RiboMed releases multi-marker methylation prognostic test for glioma

Delcath, NKI-AVL enter initial launch and training agreement for CHEMOSAT system

Delcath, NKI-AVL enter initial launch and training agreement for CHEMOSAT system

Provectus announces data from PV-10 Phase 2 study on metastatic melanoma

Provectus announces data from PV-10 Phase 2 study on metastatic melanoma

Delcath’s second generation CHEMOSAT system receives European CE Mark

Delcath’s second generation CHEMOSAT system receives European CE Mark

Positive preclinical results from Cancer Therapeutics' CTX-0294945 plus Avastin study

Positive preclinical results from Cancer Therapeutics' CTX-0294945 plus Avastin study

Navidea announces FDA extension of Lymphoseek PDUFA date by three months

Navidea announces FDA extension of Lymphoseek PDUFA date by three months

Combination treatment effective against melanoma

Combination treatment effective against melanoma

Transgenic mice to visualize metastasis and inflammation

Transgenic mice to visualize metastasis and inflammation

UCB receives FDA approval for Neupro to treat idiopathic Parkinson's, RLS

UCB receives FDA approval for Neupro to treat idiopathic Parkinson's, RLS

Melanoma on the rise especially amongst the young

Melanoma on the rise especially amongst the young

Clinical data for cabozantinib to be presented at ASCO annual meeting

Clinical data for cabozantinib to be presented at ASCO annual meeting

Combination of Avastin and Metformin may effectively reduce melanoma growth

Combination of Avastin and Metformin may effectively reduce melanoma growth

MEK1 mutation does not necessarily make BRAF mutant melanomas resistant to inhibitors

MEK1 mutation does not necessarily make BRAF mutant melanomas resistant to inhibitors

Melanoma on the rise among young adults

Melanoma on the rise among young adults

Canadian regulatory body recommendation brings melanoma patients closer to life-extending drugs

Canadian regulatory body recommendation brings melanoma patients closer to life-extending drugs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.